APA (7th ed.) Citation

Y, F., M, X., H, Y., X, L., & X, C. (2024). Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial. Diabetes, obesity & metabolism, 26(2), 772. https://doi.org/10.1111/dom.15359

Chicago Style (17th ed.) Citation

Y, Fan, Xia M, Yan H, Li X, and Chang X. "Efficacy of Beinaglutide in the Treatment of Hepatic Steatosis in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Open-label, Controlled Trial." Diabetes, Obesity & Metabolism 26, no. 2 (2024): 772. https://doi.org/10.1111/dom.15359.

MLA (9th ed.) Citation

Y, Fan, et al. "Efficacy of Beinaglutide in the Treatment of Hepatic Steatosis in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease: A Randomized, Open-label, Controlled Trial." Diabetes, Obesity & Metabolism, vol. 26, no. 2, 2024, p. 772, https://doi.org/10.1111/dom.15359.